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Background: Different hematological analyzers have different analytical performances that
are often reﬂected in the criteria for sample stability of the complete blood count. This study
aimed to assess the stability of several hematological parameters using the XN-9000 Sysmex
and  BC-6800 Mindray analyzers.
Methods: The impact of storage at room temperature and 4 ◦C was evaluated after 2, 4, 6,
8,  24, 36 and 48 h using ten normal and 40 abnormal blood samples. The variation from
the  baseline measurement was evaluated by the Steel–Dwass–Critchlow–Fligner test and by
Bland–Altman plots, using quality speciﬁcations and critical difference as the total allowable
variation.
Results: Red blood cells and reticulocyte parameters (i.e. hematocrit, mean corpuscular
volume, mean corpuscular hemoglobin concentration, red blood cell distribution width,
immature reticulocyte fractions, low-ﬂuorescence reticulocytes, middle-ﬂuorescence retic-
ulocytes, high ﬂuorescence mononuclear cells) showed less stability compared to leukocyte
and  platelet parameters (except for monocyte count and mean platelet volume). The bias
for  hematocrit, mean corpuscular volume, mean corpuscular hemoglobin concentration
and red blood cell distribution width coefﬁcient of variation was higher than the critical
difference after 8 h using both analyzers.
Conclusion: Blood samples measured with both analyzers do not show analytically signiﬁ-
cant  changes in up to 2 h of storage at room temperature and 4 ◦C. However, the maximum
time  for analysis can be extended for up to 8 h when the bias is compared to the critical
difference.
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Introduction
Modern hematological analyzers not only enable accurate
quantitative and qualitative assessment of blood cells, but also
provide a vast array of hematological parameters that may be
useful for the diagnostic and prognostic assessment of many
blood cell disorders. The vast majority of laboratory errors (up
to 70%) emerge from the pre-analytical phase.1 This phase is
inﬂuenced by a number of variables, including the preparation
of the patient before testing, the procedures used to collect
and transport the biological specimens, as well as the time
and storage conditions of blood samples before analysis. In
particular, it was recently proven that the stability of many
hematological parameters is strongly inﬂuenced by the stor-
age temperature of the sample and the time elapsed between
collection and analysis.2–4
Another factor that may have an inﬂuence on the stabil-
ity of hematological parameters is the technology used by the
different hematological analyzers.3 Basically, the instruments
currently available on the market use different methods and
technologies to assess basic parameters such as red blood
cell (RBC), platelet (PLT), total leukocyte (WBC) and leuko-
cyte subclass [neutrophils (NE), lymphocytes (LY), monocytes
(MO), eosinophils (EO), basophils (BA)] counts.5 It is for this
reason that a more  profound knowledge of the potential
impact of time and storage temperature of samples before
analysis should be regarded as a mainstay to increase the
quality of hematological testing and to improve the clinical
interpretation of data obtained with different analyzers and
techniques.2–4 Notably, the latest generation of hematological
analyzers provides a number of innovative quantitative and
qualitative parameters, such as the enumeration of high ﬂuo-
rescence mononuclear cells (HFC)5–7 and nucleated red blood
cell (NRBC) count,7 and the RBC distribution width expressed
as a standard deviation (RDW-SD) or coefﬁcient of variation
(RDW-CV).8 Moreover, they may provide platelet distribution
width (PDW), plateletcrit (PCT), mean platelet volume (MPV),
percentage of large platelet (P-LCR) parameters,5,9,10 along
with the reticulocyte count (RET) and immature reticulocyte
fractions [IRF, high-ﬂuorescence (HFR), middle-ﬂuorescence
(MFR) and low-ﬂuorescence reticulocytes (LFR)], all of which
are useful for the diagnosis and classiﬁcation of anemia or for
monitoring bone marrow erythropoiesis.11,12
The importance of verifying the stability of the aforemen-
tioned parameters is now unquestionable and published data
about blood sample stability before analysis is scarce for the
new generation of hematological analyzers. Therefore, this
study aimed to assess and compare the stability of a num-
ber of hematological parameters in normal and abnormal
blood samples measured using two novel analyzers, XN-9000
(Sysmex Co., Kobe, Japan) and BC-6800 (Mindray, Shenzhen,
China), according to the Guidelines of the International Coun-
cil for Standardization of Haematology (ICSH)4 and the Clinical
and Laboratory Standards Institute (CLSI) Document H26-P2.13Blood  samples
The study population consisted of ten adult and osten-
sibly healthy volunteers recruited from the laboratory 2 0 1 6;3  8(3):225–239
staff (ﬁve women, mean age 37.5 ± 0.8 years and ﬁve
males, mean age 35.0 ± 7.4 years). All subjects were Cau-
casian, had no diabetes mellitus, hypertension and had not
taken any medication for one month before the study. Six
venous blood samples from each subject were collected in
K3-ethylenediaminetetraacetic acid (K3-EDTA) tubes (Becton
Dickinson, Franklin Lakes, NJ). All samples were analyzed
immediately after venipuncture (i.e., within 30 min). The anal-
ysis of the impact of different storage temperatures was then
carried out by storing three blood tubes from each individual at
room temperature (RT) and three blood tubes were divided in
six aliquots and stored (refrigerated) at 4 ◦C. Repeated meas-
ures were then performed on each sample after 2 h, 4 h, 6 h,
8 h, 24 h, 36 h and 48 h of storage. An additional study was per-
formed using 40 routine samples with abnormal values, that
is, containing at least one abnormality of hemoglobin (Hb),
platelet (PLT) or white blood cell (WBC) counts or morpholog-
ical alterations (i.e., at least one morphological ﬂag for WBC).
Count abnormalities included Hb lower than 70 g/dL, PLT lower
than 100 × 109/L or higher than 400 × 109/L; WBC  lower than
1.00 × 109/L or higher than 12.00 × 109/L. Hematological test-
ing was performed immediately upon arrival in the laboratory
(i.e., within 30 min) and then each sample was divided into 8
aliquots, four were stored at 4 ◦C and four were stored at RT.
The tests were repeated after 4 h, 8 h, 24 h 36 h and 48 h of stor-
age. All measures (i.e., the baseline and the repeated analyses)
were performed in duplicate and the ﬁnal value was expressed
as the mean of the two analyses at each time point.
Study  design
The following parameters were assessed to check blood sam-
ple stability: extended complete blood count (CBC) proﬁle
parameters, including all basic CBC parameters [RBC, Hb,
hematocrit (HT)], mean corpuscular volume (MCV), mean cor-
puscular hemoglobin (MCH), mean corpuscular hemoglobin
concentration (MCHC), RDW-SD, RDW-CV and NRBC. More-
over, the extended differential counts (DIFF) (including WBC,
NE, LY, MO, EO, BA and HFC), PLT proﬁle parameters (including
PLT, PCT, MPV,  PDW and P-LCR) and the RET proﬁle (including
RET, IRF, LFR, MFR and HFR) were evaluated.
The measurements at the different time points were con-
comitantly performed with both the XN-9000 and BC-6800
analyzers. The mean analytical characteristics of the two
analyzers are summarized in Table 1. Brieﬂy, the XN-9000
and the BC-6000 analyzers perform a 5-part DIFF, RET count,
NRBC count, with ﬂags appearing in the presence of abnormal
results.7,14,15 Both analyzers use a combination of ﬂow cytom-
etry and ﬂuorescence with lysing buffers for leukocyte DIFF
and identiﬁcation of abnormal cells. A separate channel for
NRBC assessment is also available in the BC-6800.
The between-run imprecision of both the XN-9000 and
BC-6800 was evaluated according to the CLSI document EP5-
A3,16 by analysis in duplicate of three levels (i.e., level 1, 2
and 3) of control materials (XN-CHECK; Streck Laboratories
Inc., Omaha, NE, USA and BC-6D, BC-BC-RET and NRBC; Shen-
zhen Mindray Bio-Medical Electronics, Shenzhen, China) for
40 consecutive working days. The study was carried out in
accord with the Declaration of Helsinki, under the terms of all
rev bras hematol hemoter. 2 0 1 6;3  8(3):225–239 227
Table 1 – XN-9000 and BC-6800 parameters with optimal performance Bias% and Critical Difference% (CD).
Parameters XN-9000 BC-6800 Optimal
performance
Bias%
Critical
Difference%
on XN-9000
Critical
Difference% on
BC-6800
Red blood cell RBC RBC 0.9 9.1 9.3
Hemoglobin HGB HGB 0.9 7.9 8.1
Hematocrit HCT HCT 0.9 8.4 9.5
Mean volume, red blood cells MCV MCV 0.6 4.2 5.3
Mean corpuscular hemoglobin MCH MCH 0.7 5.0 5.4
Mean corpuscular hemoglobin concentration MCHC MCHC 0.4 5.8 6.7
RBC distribution width RDW-CV  RDW-CV 0.9 9.8 9.9
RDW-SD RDW-SD NA NA NA
Nucleated red blood cell NRBC NRBC NA NA NA
White blood cells WBC WBC 2.8 30.5 30.6
Neutrophil NEUT Neu 4.6 45.4 45.2
Lymphocyte LYMPH Lym 3.7 30.2 30.4
Monocyte MONO Mon 6.6 53.7 57.4
Eosinophil EO Eos 9.9 62.0 58.9
Basophil BASO Bas 7.7 77.9 88.1
High ﬂuorescence cells HFLC HFC NA NA NA
Platelet PLT PLT 3.0 26.1 26.2
Mean volume platelet MPV MPV 1.2 12.3 12.6
PLT distribution width PDW PDW NA NA NA
Plateletcrit PCT PCT NA NA NA
PLT larger cell ratio P-LCR P-LCR NA NA NA
Reticulocyte RET RET 3.9 31.7 31.1
Immature reticulocyte fraction IRF IRF NA NA NA
Low-ﬂuorescence reticulocyte LFR LFR NA NA NA
Medium-ﬂuorescence reticulocyte MFR MFR NA NA NA
High-ﬂuorescence reticulocyte HFR HFR NA NA NA
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elevant local legislation and with prior approval of the Local
thics Committee.
tatistical  analysis
he signiﬁcance of the difference of the parameters obtained
n paired samples measured with the two analyzers was
stimated according to the Steel–Dwass–Critchlow–Fligner
est, with assessment by the Hodges–Lehmann location shift
or multiple comparisons of means and medians between
ifferent groups, after veriﬁcation of value distribution by the
hapiro–Wilk test. Statistical signiﬁcance was set for p-values
0.05. The results were then reported as delta variations
rom baseline analysis immediately after collection, as X
TX − T0), where “X” is the different timing and “0” is the
aseline result. Percentage variations from the baseline result
T0) in samples with statistically signiﬁcant differences were
hen analyzed using Bland–Altman plots (Bias%) and com-
ared with the current quality speciﬁcations for optimal bias
OP-Bias%),17 that is calculated using intra-individual biolog-
cal variability (CVi) and inter-individual biological variability
CVg) following the equation: OP-Bias% = 0.250 (CVi + CVg)1/2.
ias% was also compared with the reference change values
r critical difference (CD)18,19 when these indices were avail-
ble. The CD percentage is the highest relative difference
etween two consecutive measurements, that, at a chosen
evel of probability, may still be due to the combined effect
f the analytical (Va) and biological (Vi) variations. It is given
y the following equation: CD% = K × (Va2 + Vi2)1/2, where Kdepends on the chosen probability. The comparison between
Bias% and CD% was performed only for those parameters
exhibiting a statistically signiﬁcant difference between Bias%
and OP-Bias% throughout the study period. The statistical
analysis was performed using Analyse-it software version
3.90.1 (Analyse-it Software Ltd.; Leeds, UK).
Results
Overall, 2480 measurements were performed with the XN-
9000 and BC-6800 analyzers. All results obtained in the normal
samples group were included in the statistical analysis,
whereas 160 measurements were performed in the abnormal
samples group. Unfortunately, several measurements could
not be performed due to the low residual sample volume in
this second group of samples. The results of these studies
and the relative variations according to the different storage
conditions are shown in Tables 2–5.
Red  blood  cell  parameters
The median values obtained at baseline (i.e., T0) in the normal
sample group did not signiﬁcantly differ between the two
analyzers for all the parameters tested, except for MCH  and
MCHC (Table 2). In this group of normal samples, the values
of WBC, RBC, HB, MCH and NRBC were found to be stable up
to 48 h at RT and 4 ◦C using both analyzers. Conversely, the HT
values displayed a statistically signiﬁcant increase 48 h after
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Table 2 – Samples stability of group of normal samples for CBC and RET proﬁles parameters. Median Hodges–Lehmann location shift (X); Bias% (B%) between baseline
(T0) and the time point (2 h up to 48 h) at 4 ◦C and room temperature (RT) comparison of OP-Bias% to Critical Difference % (CD).
Temp T0
median value
(95% CI)
X  (TX − T0) Hodges–Lehmann location shift X with
p-value < 0.0001
at the time [h]
B%  (95% CI) a
time of stability;
p-value
B% vs. OP-Bias%;
Stable until [h]
B% (95% CI);
p-value
B% vs. CD%;
Stable until [h]
2 h 4 h 6 h 8 h 24 h 36 h 48 h
WBC
(109/L)
XN-9000
RT
7.67  (5.91 to 9.40)
0.03  0.05 −0.03 0.06 0.07 −0.08 −0.10 NS 1.4 (−1.0 to 3.7);
p = 0.2192; 48 h
NE
4 ◦C 0.13 0.02 0.22 0.14 0.08 0.10 −0.03 NS 3.0 (−1.4 to 7.5);
p = 0.9109; 48 h
NE
BC-6800
RT
7.15 (5.60 to 7.95)
0.02  0.00 0.04 0.14 0.16 0.19 0.01 NS −0.2 (−2.5 to 2.0);
p = 0.0105; 48 h
NE
4 ◦C 0.01  0.16 0.02 0.03 0.03 0.04 −0.03 NS 0.2 (−1.0 to 1.5);
p = 0.0013; 48 h
NE
RBC
(1012/L)
XN-9000
RT
4.60  (4.23 to 5.22)
−0.01  −0.01 −0.02 0.01 0.02 0.01 0.00 NS −0.1 (−0.6 to 0.5)
p < 0.0001; 48 hb
NE
4 ◦C 0.12 0.10 0.13 0.15 0.11 0.16 0.15 NS 2.7 (0.9 to 4.5)
p = 0.0522; 48 h
NE
BC-6800
RT
4.57 (4.20 to 4.89)
0.00  0.09 0.05 −0.08 −0.06 −0.04 −0.04 NS −0.6 (−3.9 to 2.7);
p = 0.3477; 48 h
NE
4 ◦C 0.06 0.08 0.06 0.09  0.09 0.08 0.09 NS 1.6 (0.4 to 2.9);
p = 0.2163; 24 h
NE
Hb (g/L)
XN-9000
RT
142  (126 to 151)
0.10  0.20 0.10 0.20 0.30 0.20 0.10 NS 1.0 (0.6 to 1.4)
p = 0.5780; 48 h
NE
4 ◦C 0.40 0.35 0.40 0.30 0.35 0.35 0.40 NS 3.7 (2.0 to 5.4);
p < 0.0001c
−0.6 (−1.4 to 0.6);
p < 0.0001; 48 hd
BC-6800
RT
146  (134 to 151)
0.00  0.00 0.00 −0.20 −0.15 −0.20 −0.10 NS −1.4 (−4.3 to 1.5);
p = 0.1119; 48 h
NE
4 ◦C 0.20 0.20 0.10 0.20 0.20 0.20 0.20 NS 1.3 (0.9 to 1.6);
p = 0.0640; 48 h
NE
HT
(%)
XN-9000
RT
41.6 (37.2 to 43.7)
−0.37  −0.63 −0.56 −0.40 2.11 3.25 6.12 48 h 0.9 (−1.6 to 3.5);
p = 0.9747; 8 h
4.9  (2.2 to 7.6);
p < 0.0001; 24 hd
4 ◦C 0.25 0.25 0.40 0.80 0.95 1.35 1.90 NS 2.3 (0.8 to 3.9);
p = 0.0740; 24 h
4.7  (3.3 to 6.4);
p < 0.0001; 48 hd
BC-6800
RT
41.4  (40.2 to 44.1)
−0.05  0.35 0.20 −0.60 2.15 3.90 6.00 48 h 1.9 (−1.0 to 4.8);
p = 0.4791; 8 h
4.9  (1.9 to 8.0)
p < 0.0001; 24 hd
4 ◦C 0.20 0.40 0.00 0.50 0.90 1.30 2.00 NS 1.6 (0.7 to 2.6);
p = 0.1300; 24 h
4.1  (3.2 to 5.0);
p < 0.0001; 48 hd
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Table 2 – (Continued)
Temp T0
median value
(95% CI)
X (TX − T0) Hodges–Lehmann location shift X with
p-value < 0.0001
at the time [h]
B% (95% CI) a
time of stability;
p-value
B% vs. OP-Bias%;
Stable until [h]
B% (95% CI);
p-value
B% vs. CD%;
Stable until [h]
2 h 4 h 6 h 8 h 24 h 36 h 48 h
MCV
(fL)
XN-9000
RT
87.45 (86.2 to 90.5)
−0.42  −1.24 −1.02 −1.27 3.51 6.10 13.1 24 h 0.5 (0.2 to 0.7);
p = 0.3676; 2 h
−1.5 (−2.1 to
−0.8);
p < 0.0001; 8 hd
4 ◦C −1.25 −1.30 −1.40 −1.00 0.10 0.50 2.00 NS 0.3 (−0.2 to 0.8);
p = 0.2932; 24 h
2.0 (1.3 to 2.7);
p < 0.0001; 48 hd
BC-6800
RT
89.8 (88.2 to 92.7)
−0.25  −0.45 −0.50 −0.35 5.70 8.80 13.4 24 h −0.2 (−0.8 to 0.5);
p = 0.1688; 8 h
−0.2 (−0.8 to 0.5);
p < 0.0001; 8 hd
4 ◦C −1.50 −1.40 −1.55 −1.10 −0.15 0.70 1.55 NS 0.8 (0.3 to 1.4);
p = 0.3793; 36 h
2.1 (1.3 to 2.9);
p < 0.0001; 48 hd
MCHa
(pg)
XN-9000
RT
30.0  (29.0 to 30.6)
0.30 0.40  0.50 0.40 0.50 0.30 0.30 NS 1.1 (0.6 to 1.6);
p = 0.1069; 48 h
NE
4 ◦C 0.40 0.40  0.40 0.30 0.20 0.10 0.20 NS 0.6 (0.1 to 1.1);
p = 0.7434; 48 h
NE
BC-6800
RT
31.4 (30.7 to 32.3)
−0.20  −0.30 −0.30 −0.30 −0.30 −0.50 −0.30 NS 0.9 (0.2 to 1.6);
p = 0.5672; 48 h
NE
4 ◦C −0.30 −0.30 −0.10 −0.30 −0.30 −0.30 −0.30 NS 0.8 (0.1 to 1.8);
p = 0.8085; 48 h
NE
MCHCa
(g/dL)
XN-9000
RT
34.2  (33.4 to 34.4)
0.60  0.80 1.00 0.90 −0.80 −1.90 −4.20 4 h 1.7 (1.1 to 2.6);
p < 0.0001c
−2.4 (−3.5 to
−1.3);
p < 0.0001; 8 hd
4 ◦C 1.10 0.90 1.10 0.80 0.40 0.10 −0.50 2 h 3.1 (2.5 to 3.7);
p < 0.0001c
1.4 (0.6 to 2.2);
p < 0.0001; 48 hd
BC-6800
RT
35.6 (33.4 to 36.2)
−0.10  −0.30 −0.10 −0.20 −2.30 −3.50 −4.90 24 h −0.7 (−1.2 to −0.2);
p = 0.2126; 8 h
−0.7 (−1.2 to
−0.2);
p < 0.0001; 8 hd
4 ◦C 0.20 0.10 0.30 0.00 −0.40 −0.60  −1.10 48 h 0.9 (0.3 to 1.4);
p = 0.1027; 24 h
2.9 (2.1 to 3.7);
p < 0.0001; 48 hd
RDW-CV
(%)
XN-9000
RT
12.9  (12.7 to 13.1)
0.00  0.00 0.10 0.10 0.70 1.20 1.50 24 h 0.9 (0.4 to 1.4);
p = 0.9785; 8 h
8.7 (7.6 to 9.8);
p < 0.0001; 48 hd
4 ◦C −0.10 −0.10 −0.10 −0.10 −0.30 −0.30 −0.30 24 h 0.9 (0.6 to 1.3);
p = 0.8055; 8 h
2.3 (1.4 to 3.1);
p < 0.0001; 48 hd
BC-6800
RT
12.9 (12.4 to 13.2)
0.00  0.20 0.30 0.30 1.20 1.60 1.90 24 h 0.5 (0.1 to 0.8);
p < 0.0001; 2 hb
2.7 (2.0 to 3.3);
p < 0.0001; 8 hd
4 ◦C 0.10 0.20 0.20 0.20 −0.10 0.00 −0.10 NS 0.3 (−0.3 to 1.0);
p = 0.0912; 48 h
NE
RDW-SD
(fL)
XN-9000
RT
41.4 (39.4 to 43.2)
−0.10  −0.70 −0.25 −0.55 4.40 7.00 12.0 24 h 10.2 (8.6 to 11.8)
CD% data not
available
4 ◦C −1.10 −1.20 −1.10 −1.10 −1.20 −1.10 −0.50 NS 0.9 (−0.4 to 2.2)
BC-6800
RT
40.5 (39.5 to 41.5)
0.00  0.50 0.70 0.90 7.15 10.1 12.8 24 h 14.9 (12.5 to 17.4)
4 ◦C −0.15 0.00 0.00 0.10 −0.20 0.50 0.50 NS 0.9 (0.0 to 1.9)
230
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Table 2 – (Continued)
Temp T0
median value
(95% CI)
X (TX − T0) Hodges–Lehmann location shift X with
p-value < 0.0001
at the time [h]
B%  (95% CI) a
time of stability;
p-value
B% vs. OP-Bias%;
Stable until [h]
B% (95% CI);
p-value
B% vs. CD%;
Stable until [h]
2 h 4 h 6 h 8 h 24 h 36 h 48 h
NRBC
(109/L)
XN-9000
RT
0.0  (0.0 to 0.0)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 NS 20.0 (−31.7 to 71.7)
4 ◦C 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NS 0.0 (−42.9 to 42.9)
BC-6800
RT
0.0 (0.0 to 0.0)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 NS 0.0 (0.0 to 0.0)
4 ◦C 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NS 0.0 (0.0 to 0.0)
RETa
(109/L)
XN-9000
RT
48.1  (35.1 to 60.3)
0.63 −0.89 −1.05  −1.50 −3.71 −0.59 −1.77 NS 2.5 (−1.5 to 6.6);
p = 0.4964; 48 h
NE
4 ◦C 1.01 1.15 0.36 0.08 −0.07 0.27 −0.11  NS 0.3 (−3.9 to 4.4);
p = 0.0840; 48 h
NE
BC-6800
RT
37.4 (26.8 to 44.4)
0.85 1.55 0.30 −1.10 0.45 −1.20  −2.60 NS 6.1 (0.3 to 12.0);
p = 0.4344; 36 h
9.8  (4.5 to 15.1);
p < 0.0001; 48 hd
4 ◦C 0.00 0.50 −1.30 0.25 1.30 1.65 3.45 NS 5.0 (1.2 to 8.8);
p = 0.5394; 36 h
10.7  (6.2 to 15.2);
p < 0.0001; 48 hd
IRFa
(%)
XN-9000
RT
9.3  (6.9 to 10.3)
−0.81 −0.49 −1.08 −1.37 −1.94 −1.85 −2.07 24 h −25.1 (−38.7 to −11.5)
CD% data not
available
4 ◦C 0.15 −0.98 −0.42 −0.96 −0.64 −0.66 0.45 NS 4.0 (−5.3 to 13.4)
BC-6800
RT
3.4 (2.5 to 4.3)
0.20 0.20 0.20 −0.20 −0.85 −1.35 −2.00 36 h −90.2 (−110.8 to −69.6)
4 ◦C 0.0 −0.80 −0.60 −0.70 0.10 0.50 0.90 NS 22.1 (4.4 to 39.6)
LFRa
(%)
XN-9000
RT
90.7  (89.7 to 93.1)
0.81  0.48 1.08 1.37 1.94 1.85 2.07 24 h 2.1 (1.0 to 3.2)
4 ◦C −0.16 0.98 0.42 0.96 0.64 0.66 −0.45 NS −0.5 (−1.4 to 0.4)
BC-6800
RT
96.5 (95.7 to 97.5)
−0.20  −0.20 −0.20 0.20 0.85 1.35 2.00 36 h 2.1 (1.5 to 2.7)
4 ◦C 0.00 0.80 0.60 0.70 −0.10 −0.50 −0.90 NS −0.8 (−1.3 to −0.2)
MFRa
(%)
XN-9000
RT
8.4  (6.5 to 8.9)
−0.72 −0.43 −1.02 −1.20 −1.58 −1.70 −1.68 24 h −23.7 (−37.6 to −9.7)
4 ◦C 0.15 −0.78 −0.48 −0.82 −0.77 −0.66 0.04 NS −0.9 (−11.2 to 9.5)
BC-6800
RT
3.4 (2.5 to 4.3)
0.20 0.20 0.20 −0.20 −0.85 −1.35 −2.00 36 h −90.2 (−67.9 to −35.5)
4 ◦C 0.00 −0.80 −0.60 −0.70 0.10 0.50 0.90 NS 22.0 (4.4 to 39.7)
HFRa
(%)
XN-9000
RT
0.9  (0.6 to 1.3)
0.00 0.00 −0.10 −0.10 −0.30 −0.10 −0.30 NS −51.1 (−79.2 to −23.0)
4 ◦C 0.10 −0.15 0.10 −0.10 0.10 0.10 0.40 NS 46.8 (21.2 to 72.4)
BC-6800
RT
0.0 (0.0 to 0.0)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 NS 0.0 (0.0 to 0.0)
4 ◦C 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NS 0.0 (0.0 to 0.0)
WBC: white blood cells; RBC: red blood cell; RT: Room temperature; Hb: hemoglobin; HT: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular
hemoglobin concentration; RDW-CV: distribution-coefﬁcient of variation; RDW-SD: RBC distribution width-standard deviation; NRBC: nucleated red blood cell; RET: reticulocyte; IRF: immature
reticulocyte fraction; LFR: low-ﬂuorescence reticulocyte; MFR: medium-ﬂuorescence reticulocyte; HFR: high-ﬂuorescence reticulocyte; NS: X not signiﬁcant throughout the study period; NE: not
evaluated; Temp: Temperature.
a Parameters with median value a T0 signiﬁcant difference between two analyzer in the same samples with p < 0.0001.
b Bias% (between baseline T0 and the time point X) is lower than OP-Bias%.
c Bias% (between baseline T0 and the time point X) is always higher than OP-Bias%.
d Bias% (between baseline T0 and the time point X) is lower than CD%.
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Table 3 – Samples stability on group of pathological samples for: CBC and RET proﬁles parameters. Median
Hodges–Lehmann location shift (X); Bias% (B%) between baseline (T0) and the time point (4 h up to 8 h) at 4 ◦C and room
temperature (RT) comparison of OP-Bias% to Critical Difference% (CD).
Temp T0 median value
(95% CI)
X  (TX − T0)
Hodges–Lehmann
location shift
X  with
p-value < 0.0001
at the time [h]
B% (95% CI) a
time of stability;
p-value
B% vs. OP-Bias%;
Stable until [h]
B% (95% CI);
p-value
B% vs. CD%;
Stable until [h]
4 h 8 h
WBC
(109/L)
XN-9000
RT 5.3 (4.3 to 7.2) 0.00 −0.10 NS −0.8 (−6.8 to 5.2);
p = 0.2229; 8 h
NE
4 ◦C 8.6 (6.5 to 10.1) 0.06 0.04 NS 0.6 (−4.5 to 5.6);
p = 0.37625; 8 h
NE
BC-6800
RT 5.4 (4.1 to 7.1) 0.05 −0.10 NS  2.3 (−0.9 to 5.5);
p = 0.3274; 8 h
NE
4 ◦C 8.5 (6.4 to 9.9) 0.20 −1.22 NS 1.8 (0.7 to 2.9);
p = 0.0774; 4 h
18.4 (7.2 to 29.7);
p < 0.0001; 8 ha
RBC
(1012/L)
XN-9000
RT 4.8  (3.8 to 5.6) 0.01 −0.16  NS −4.0 (−17.8 to 9.8);
p = 0.4582; 8 h
NE
4 ◦C 3.6 (3.5 to 3.9) −0.02 −0.02 NS −0.4 (−2.1 to 1.2);
p = 0.1161; 8 h
NE
BC-6800
RT 4.6 (3.7 to 5.3) −0.02 −0.01 NS 0.3 (−1.1 to 1.8);
p = 0.4194; 8 h
NE
4 ◦C 3.5 (3.3 to 3.8) −0.01 0.26 NS 8.5 (−0.5 to 17.5);
p = 0.0945; 8 h
NE
Hb
(g/L)
XN-9000
RT 141.0 (123.0 to 152.0) 0.10 −0.70 NS −5.2 (−19.7 to 9.2);
p = 0.3370; 8 h
NE
4 ◦C 113.0 (101.0 to 116.0) 0.00 0.00 NS 0.5 (−0.4 to 1.3);
p = 3067; 8 h
NE
BC-6800
RT 141.0 (123.0 to 154.0) −0.10 −0.20 NS −0.8 (−4.3 to 2.7);
p = 0.3108; 8 h
NE
4 ◦C 111.0 (103.0 to 117.0) 0.00 1.30 NS 1.6 (0.07 to 3.12);
p = 0.3546; 8 h
NE
HT
(%)
XN-9000
RT 40.7 (35.3 to 46.5) 0.40 −1.40 NS −3.5 (−17.4 to 10.3);
p = 0.5044; 8 h
NE
4 ◦C 33.9 (31.5 to 35.5) 0.00 0.00 NS 0.1 (−0.7 to 0.9);
p = 0.0614; 8 h
NE
BC-6800
RT 39.7 (34.5 to 44.3) 0.00 0.00 NS 1.3 (−0.3 to 2.9);
p = 0.5982; 8 h
NE
4 ◦C 32.6 (30.6 to 34.4) 0.00 0.02 NS 8.6 (−0.5 to 17.7);
p = 0.0921; 8 h
NE
MCV
(fL)
XN-9000
RT 84.8 (84.0 to 88.4) 0.60 0.30 NS 0.5 (0.1 to 0.8);
p = 0.4860; 8 h
NE
4 ◦C 89.9 (87.7 to 92.5) 0.40 0.40 NS 0.5 (−0.3 to 1.4);
p = 0.8606; 8 h
NE
BC-6800
RT 85.8 (84.5 to 88.7) 0.60 0.80 NS 0.5 (0.4 to 0.7);
p = 0.3379; 4 h
1.0 (0.8 to 1.2);
p < 0.0001; 8 ha
4 ◦C 92.4 (87.1 to 93.5) 0.20 0.10 NS 0.1 (0.0 to 0.3);
p < 0.0001; 8 hb
NE
MCH
(pg)
XN-9000
RT 28.9 (27.3 to 29.8) 0.07 −0.33 NS 1.2 (0.1 to 2.4);
p = 0.3425; 8 h
NE
4 ◦C 29.6 (27.2 to 30.9) 0.20 0.00 NS −0.1 (−1.0 to 0.8);
p = 0.0961; 8 h
NE
BC-6800
RT 30.3 (28.9 to 31.4) 0.00 0.10 NS −1.1 (−4.0 to 1.8);
p = 0.2119; 8 h
NE
4 ◦C 31.3 (28.2 to 32.4) 0.10 0.85 NS 0.20 (−0.07 to 0.05);
p = 0.1530; 4 h
3.9 (2.8 to 5.4)
p < 0.0001; 8 ha
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Table 3 – (Continued)
Temp T0 median value
(95% CI)
X  (TX − T0)
Hodges–Lehmann
location shift
X  with
p-value < 0.0001
at the time [h]
B% (95% CI) a
time of stability;
p-value
B% vs. OP-Bias%;
Stable until [h]
B% (95% CI);
p-value
B% vs. CD%;
Stable until [h]
4 h 8 h
MCHC
(g/dL)
XN-9000
RT 33.6 (32.5 to 34.5) −0.10 −0.60 NS 0.5 (−0.3 to 1.2);
p = 0.8634; 4 h
NE
4 ◦C 32.9 (32.4 to 33.5) 0.02 −0.20 NS 0.6 (0.3 to 0.9);
p = 0.1932; 8 h
NE
BC-6800
RT 35.3 (34.7 to 35.6) −0.35 −0.40 NS  −2.1 (−5.0 to 0.8);
p = 0.812; 8 h
NE
4 ◦C 34.1 (33.7 to 34.3) 0.10 0.85 8 h 0.0 (−0.3 to 0.3);
p < 0.0001b; 4 h
3.8  (1.6 to 6.1);
p < 0.0001; 8 ha
RDW-CV
(%)
XN-9000
RT 13.3  (13.1 to 15.9) 0.20 0.35 NS 2.8 (−9.7 to 15.4);
p < 0.7469; 8 h
NE
4 ◦C 14.2 (13.4 to 14.6) 0.10 0.10 NS 0.7 (0.1 to 1.2);
p = 0.4190; 8 h
NE
BC-6800
RT 13.4 (13.0 to 15.6) 0.30 0.50 NS 2.1 (1.8 to 2.4);
p < 0.0001c
3.6 (2.9 to 4.2);
p < 0.0001; 8 ha
4 ◦C 13.7 (13.4 to 14.1) 0.10 0.25 NS 0.9 (0.5 to 1.2);
p = 0.9609; 4 h
2.1 (1.2 to 2.9);
p < 0.0001; 8 ha
RDW-SD
(fL)
XN-9000
RT 42.3 (41.1 to 44.3) 1.00 1.85 NS 3.6 (−9.0 to 16.2);
p = 0.6544; 8 h
CD% data not
available
4 ◦C 44.2 (43.1 to 48.4) 0.50 0.60 NS 1.2 (−0.2 to 2.5);
p = 0.6629; 8 h
BC-6800
RT 41.5 (40.3 to 43.3) 1.20 2.00 8 h 4.3 (3.6 to 5.1)
4 ◦C 42.7 (41.9 to 47.8) 0.40 0.90 NS 2.0 (1.0 to 2.9)
NRBC
(109/L)
XN-9000
RT 0.0 (0.0 to 0.0) 0.00 0.01 8 h 103.3 (41.9 to 164.8)
4 ◦C 0.0 (0.0 to 0.0) 0.01 0.02 4 h 129.9 (95.5 to 164.4)
BC-6800
RT 0.0 (0.0 to 0.0) 0.00 0.00 NS 78.6 (26.4 to 130.8)
4 ◦C 0.0 (0.0 to 0.0) 0.00 0.02 8 h 124.0 (78.5 to 169.6)
RET
(109/L)
XN-9000
RT 53.1 (46.3 to 72.1) 0.11 −3.39 NS −4.4 (−24.8 to 16.1);
p = 0.3996; 8 h
NE
4 ◦C 54.0 (46.0 to 68.1) 1.20 1.50 NS 3.0 (−0.1 to 6.1);
p = 0.5427; 8 h
NE
BC-6800
RT 41.5 (31.9 to 55.2) 2.30 3.55 NS 7.3 (3.3 to 11.4);
p = 0.0912; 8 h
NE
4 ◦C 52.2 (41.1 to 60.1) 1.14 3.45 NS 5.4 (−5.2 to 16.0);
p = 0.7652; 8 h
NE
IRF
(%)
XN-9000
RT 6.6 (4.1 to 7.9) 0.00 0.60 NS 6.1 (−28.3 to 40.5)
CD%  data not
available
4 ◦C 15.5 (11.5 to 20.5) 0.20 0.10 NS −0.1 (−6.5 to 6.3)
BC-6800
RT 1.7 (0.9 to 2.5) −0.20 −0.30 NS −8.5 (−28.5 to 11.5)
4 ◦C 8.4 (5.0 to 12.9) −0.60 −0.80 NS −21.5 (−44.7 to 1.7)
LFR
(%)
XN-9000
RT 93.4 (92.1 to 95.9) 0.00 −0.60 NS −0.7 (−6.5 to 5.0)
4 ◦C 84.6 (79.5 to 88.5) −0.20 −0.10 NS −0.7 (−2.6 to 1.1)
BC-6800
RT 98.3 (97.5 to 99.1) 0.20 0.30 NS 0.1 (−0.5 to 0.6)
4 ◦C 91.7 (87.1 to 95.0) 0.60 0.80 NS 0.7 (0.2 to 1.2)
MFR
(%)
XN-9000
RT 6.1 (4.0 to 6.9) 0.15 0.60 NS 6.8 (−22.5 to 36.2)
4 ◦C 12.0 (10.6 to 13.8) −0.55 −0.40 NS −5.6 (−10.7 to −0.5)
BC-6800
RT 1.7 (0.9 to 2.5) −0.20 −0.30 NS −8.9 (−28.9 to 11.1)
4 ◦C 8.0 (5.0 to 11.6) −0.30 −0.60 NS −18.9 (−42.5 to 4.8)
HFR
(%)
XN-9000
RT 0.5 (0.1 to 1.0) 0.00 0.00 NS 6.9 (−56.2 to 70.0)
4 ◦C 2.8 (1.4 to 7.9) 0.40 0.30 NS 19.0 (−2.1 to 40.1)
BC-6800
RT 0.0 (0.0 to 0.0) 0.00 0.00 NS 2.6 (−1.7 to 6.9)
4 ◦C 0.0 (0.0 to 1.2) 0.00 0.00 NS −38.8 (−70.2 to −7.4)
WBC: white blood cells; RBC: red blood cell; RT: Room temperature; Hb: hemoglobin; HT: hematocrit; MCV: mean corpuscular volume; MCH:
mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW-CV: distribution-coefﬁcient of variation; RDW-SD:
RBC distribution width-standard deviation; NRBC: nucleated red blood cell; RET: reticulocyte; IRF: immature reticulocyte fraction; LFR: low-
ﬂuorescence reticulocyte; MFR: medium-ﬂuorescence reticulocyte; HFR: high-ﬂuorescence reticulocyte; NS: X not signiﬁcant throughout the
study period; NE: not evaluated; Temp: Temperature.
a Bias% (between baseline T0 and the time point X) is lower than CD%.
b Bias% (between baseline T0 and the time point X) is lower than OP-Bias%.
c Bias% (between baseline T0 and the time point X) is always higher than OP-Bias%.
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Table 4 – Samples stability of group of normal samples for: DIFF and PLT proﬁles parameters. Median Hodges–Lehmann location shift (X); Bias% (B%) between baseline
(T0) and the time point (2 h up to 48 h) at 4 ◦C and room temperature (RT) comparison of OP-Bias% to Critical Difference% (CD).
Temp  T0  median  value
(95%  CI)
X  (TX  −  T0)  Hodges–Lehmann  location  shift  X  with  p  <  0.0001
at  the  time  [h]
B%  (95%  CI)  a
time  of  stability;
p-value
B%  vs.  OP-Bias%;
Stable  until  [h]
B%  (95%  CI);
p-value
B%  vs.  CD%;
Stable  until  [h]2  h 4  h 6  h 8  h 24  h 36  h 48 h
NE
(109/L)
XN-9000
RT
4.4  (3.5  to  4.7)
0.01  0.08  −0.02  0.00  0.21  0.06  0.00  NS  0.5  (−3.1  to  4.1);
p  =  0.0273;  48  h
NE
4 ◦C 0.07 0.07 0.09  0.06  0.04  0.14  0.13  NS  2.5  (−3.4  to  8.3);
p  =  0.4509;  48  h
NE
BC-6800
RT
4.0  (3.0  to  4.6)
0.17  0.12  0.09  0.21  0.40  0.27  0.42  NS  3.5  (0.9  to  6.1);
p  =  0.3950;  48  h
NE
4 ◦C  0.02  0.10  0.00  0.05  0.23  0.34  0.51  NS  11.0  (7.1  to  14.8);
p  =  0.1137;  24  h
NE
LY
(109/L)
XN-9000
RT
2.3  (1.7  to  2.5)
−0.02 −0.02  −0.07  −0.05  0.00  0.03  0.05  NS  1.1  (−1.7  to  3.9);
p  =  0.0626;  48  h
NE
4 ◦C  −0.03  0.01  −0.02  0.00  −0.09  −0.06  −0.11  NS  7.6  (3.1  to  12.1);
p  =  0.0885;  48  h
NE
BC-6800
RT
2.0  (1.6  to  2.3)
0.01  0.00  0.02  0.02  0.02  0.00  −0.01  NS  1.0  (−2.7  to  4.7);
p  =  0.1480;  48  h
NE
4 ◦C  −0.01  −0.02  −0.03  0.00  −0.13  0.12  0.24  NS  0.3  (−2.9  to  −3.47);
p  =  0.0372;  8  h
16.4  (11.1  to  21.7);
p  <  0.0001;  48  hb
MOa
(109/L)
XN-9000
RT
0.6  (0.6  to  0.9)
0.00  0.00  −0.01  −0.01  −0.12  −0.15  −0.03  NS  16.0  (5.0  to  27.0);
p  =  0.0884;  48  h
NE
4 ◦C 0.02 0.00 0.02 0.02  −0.01  −0.06  −0.17  NS  8.8  (1.94  to  −15.7);
p  =  0.5053;  24  h
28.1  (19.1  to  37.1);
p  <  0.0001;  48  hb
BC-6800
RT
0.5  (0.4  to  0.7)
0.00  0.00  0.01  0.00  −0.04  −0.04  −0.12  48  h  12.3  (5.1  to  19.4);
p  =  0.1128;  36  h
33.2  (24.7  to  41.6);
p  <  0.0001;  48  hb
4 ◦C  0.02  0.03  0.02  0.01  −0.01  −0.07  −0.13  48  h  3.4  (−1.5  to  8.2);
p  =  0.1816;  24  h
36.7  (28.6  to  44.8);
p  <  0.0001;  48  hb
EO
(109/L)
XN-9000
RT
0.2  (0.1  to  0.3)
0.00  0.01  0.02  0.03  −0.02  −0.05  −0.01  NS  14.5  (2.0  to  −26.9);
p  =  0.4507;  48  h
NE
4 ◦C  0.00  0.00  0.01  0.00  0.01  0.00  0.00  NS  0.4  (−11.7  to  12.5);
p  =  0.1175;  48  h
NE
BC-6800
RT
0.1  (0.1  to  0.3)
0.01  0.00  0.01  0.01  0.00  0.01  0.00  NS  6.1  (−1.2  to  13.4);
p  =  0.2908;  48  h
NE
4 ◦C  0.01  0.01  0.00  0.01  0.01  0.01  0.01  NS  10.01  (0.9  to  19.3);
p =  0.966;  48  h
NE
BA
(109/L)
XN-9000
RT
0.1  (0.0  to  0.1)
0.00  0.00  0.00  0.00  0.01  0.01  0.01  NS  20.2  (−4.5  to  44.9);
p  =  0.3032;  48  h
NE
4 ◦C  0.00  0.00  0.00  0.00  0.00  0.00  0.01  NS  26.1  (1.3  to  50.9);
p  =  0.1362;  48  h
NE
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Table 4 – (Continued)
Temp T0  median  value
(95%  CI)
X  (TX  −  T0)  Hodges–Lehmann  location  shift X  with  p  <  0.0001
at  the  time  [h]
B%  (95%  CI)  a
time  of  stability;
p-value
B%  vs.  OP-Bias%;
Stable  until  [h]
B%  (95%  CI);
p-value
B%  vs.  CD%;
Stable  until  [h]2  h  4  h  6  h  8  h  24  h  36  h  48  h
BC-6800
RT
0.0  (0.0  to  0.0)
0.00  0.00  0.00  0.00  0.00  0.00  0.00  NS  3.8  (−9.9  to  17.4);
p  = 0.5552;  48  h
NE
4 ◦C  0.00  0.00  0.00  0.00  0.00  0.00  0.00  NS  10.5  (−10.8  to  30.9);
p  = 0.7777;  48  h
NE
HFC
(109/L)
XN-9000
RT
0.0  (0.0  to  0.0)
0.00  0.00  0.00  0.00  −0.01  −0.01  −0.01  NS  −88.3  (−134.8  to  −41.9)
CD%  data  not
available
4 ◦C  0.00  0.00  0.00  0.00  0.00  0.00  0.00  NS  −26.7  (−73.9  to  20.6)
BC-6800
RT
0.0  (0.0  to  0.0)
0.00  0.00  0.00  0.00  0.00  0.00  0.00  NS  −28.7  (−84.4  to  27.1)
4 ◦C 0.00  0.00  0.00  0.00  0.00  0.00  0.00  NS  −58.0  (−112.1  to  −3.9)
PLT
(109/L)
XN-9000
RT 262.0  (231.0  to
299.0)
−1.0 3.0 −3.0  −1.0  −19.0  −15.0  −10.0  NS  5.2  (1.9  to  8.5);
p  = 0.1847;  48  h
NE
4 ◦C  −14.5  −16.5  −20.5 −19.0  −21.0  −19.5  −23.0  NS  6.0  (4.0  to  8.0);
p  < 0.0001c
9.5  (6.1  to  12.8);
p  <  0.0001;  48  hb
BC-6800
RT 250.0  (227.0  to
279.0)
9.0  7.0  12.0  6.5  3.0  7.0  5.0  NS  4.0  (1.2  to  6.8);
p  = 0.0045;  48  h
NE
4 ◦C  4.0  3.0  4.0  −1.0  −3.0  −2.0 −5.0  NS  −0.6  (−2.9  to  1.7);
p  = 0.4497;  48  h
NE
MPVa (fL)
XN-9000
RT
10.8  (10.2  to  11.3)
0.40  0.50  0.60  0.60  1.30  1.50  0.90  24  h  3.7  (2.9  to  4.5);  p  <  0.0001c 9.2  (6.9  to  1.0);
p  <  0.0001;  48  hb
4 ◦C  0.00  −0.10  0.20  0.10  0.50  0.60  0.90  48  h  0.8  (−0.4  to  1.5);
p  = 0.1719.  8  h
5.7  (4.3  to  7.0);
p  <  0.0001;  48  hb
BC-6800
RT
9.5  (9.1  to  9.9)
0.60  0.80  1.00  0.80  0.80  0.80  1.10  4  h  6.1  (4.9  to  7.2);  p  <  0.0001c 8.8  (5.7  to  11.9);
p  <  0.05;  24  hb
4 ◦C  0.60  0.50  0.70  0.60  0.90  1.00  1.20  24  h  1.3  (1.1  to  1.4);
p  = 0.5307;  48  h
1.3  (1.1  to  1.4);
p  <  0.0001;  48  hb
PDWa
(fL)
XN-9000
RT
12.5  (11.8  to  14.0)
0.70  0.90  1.00  0.90  1.30  3.40  2.05  24  h  19.7  (14.7  to  24.3)
CD%  data  not
available
4 ◦C 0.20 −0.20  0.40  0.00  1.00  1.30  2.00  48  h  13.7  (10.9  to  16.4)
BC-6800
RT 10.95  (10.40  to
11.30)
0.80  1.10  1.20  1.10  1.30  1.20  1.50  24  h  1.3  (0.5  to  2.0)
4 ◦C  1.00  0.60  1.25  1.30  1.60  1.60  2.10  24  h  1.7  (1.1  to  2.3)
PCTa (%)
XN-9000
RT
0.28  (0.25  to  0.33)
0.01  0.01  0.01  0.01  0.02  0.03  0.02  NS  7.2  (3.9  to  10.5)
4 ◦C  −0.02  −0.02  0.02  −0.02  −0.01  −0.01  0.00  NS  −2.3  (−4.8  to  0.3)
BC-6800
RT
0.2 (0.2  to  0.3)
0.02  0.02  0.03  0.03  0.02  0.02  0.03  NS  15.4  (10.5  to  20.4)
4 ◦C 0.02 0.01  0.02  0.01  0.02  0.03  0.30  NS  11.6  (8.5  to  14.7)
P-LCRa
(%)
XN-9000
RT
32.3  (27.4  to  36.0)
3.65  4.20  5.00  4.45  10.70  12.00  7.40  24  h  30.3  (23.2  to  37.3)
4 ◦C  0.05  −0.70  1.25  0.40  3.55  5.00  6.95  48  h  20.1  (18.1  to  22.2)
BC-6800
RT
23.4  (19.8  to  25.5)
3.80  5.00  6.00  5.30  5.05  5.00  6.80  6  h  30.1  (19.1  to  41.0)
4 ◦C  3.95  3.00  4.65  4.20  6.40  6.90  8.25  24  h  33.0  (28.0  to  38.0)
NE:  neutrophil;  LY:  lymphocyte;  MO:  monocyte;  RT:  Room  temperature;  EO:  eosinophil;  BA:  basophil;  HFC:  HIGH  ﬂuorescence  cells;  PLT:  platelet;  MPV:  mean  volume  platelet;  PDW:  PLT  distribution  width;
PCT:  plateletcrit;  P-LCR:  PLT  larger  cell  ratio;  NS:  X  not  signiﬁcant  throughout  the  study  period;  NE:  not  evaluated;  Temp:  Temperature.
a Parameters  with  median  value  a  T0  signiﬁcant  difference  between  two  analyzer  in  the  same  samples  with  p  <  0.0001.
b Bias%  (between  baseline  T0  and  the  time  point  X)  is  lower  than  CD%.
c Bias%  (between  baseline  T0  and  the  time  point  X)  is  always  higher  than  OP-Bias%.
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Table 5 – Samples stability of group of pathological samples for DIFF and PLT proﬁles parameters. Median
Hodges–Lehmann location shift (X); Bias% (B%) between baseline (T0) and the time point (4 h up to 8 h) at 4 ◦C and room
temperature (RT) comparison of OP-Bias% to Critical Difference% (CD).
Temp T0 median value
(95% CI)
X (TX − T0)
Hodges–Lehmann
location shift
X  with
p-value < 0.0001
at the time [h]
B% (95% CI) a
time of stability;
p-value
B% vs. OP-Bias%;
Stable until [h]
B%  (95% CI);
p-value
B% vs. CD%;
Stable until [h]
4 h 8 h
NE
(109/L)
XN-9000
RT  2.9 (2.3 to 4.5) −0.03 −0.09 NS 0.2 (−8.9 to 9.3);
p = 0.3146; 8 h
NE
4 ◦C 5.8 (4.2 to 7.6) 0.07 0.03 NS 1.0 (−1.2 to 3.1);
p = 0.015; 8 h
NE
BC-6800
RT 3.0 (2.3 to 4.6) 0.01 −0.03 NS 1.2 (−1.8 to 4.3);
p = 0.0324; 8 h
NE
4 ◦C 5.9 (4.3 to 7.7) 0.12 −0.87 NS 2.2 (0.8 to 3.6);
p = 0.0017; 4 h
18.7  (6.9 to 30.6);
p < 0.0001; 8 ha
LY
(109/L)
XN-9000
RT  1.6 (0.9 to 2.2) 0.02 −0.02 NS −2.8 (−33.2 to 27.5);
p = 0.6514; 8 h
NE
4 ◦C 1.2 (1.0 to 1.8) −0.01 0.00 NS −1.7 (−15.1 to 11.8);
p = 0.4237; 8 h
NE
BC-6800
RT 1.6 (0.9 to 2.2) −0.02 −0.04 NS 4.4 (0.2 to 8.5);
p = 0.7316; 8 h
NE
4 ◦C 1.2 (0.9 to 1.7) −0.01 −0.17 NS 0.9 (−1.9 to −3.7);
p = 0.0559; 4 h
13.3  (4.7 to 21.4);
p < 0.0001; 8 ha
MO
(109/L)
XN-9000
RT  0.5 (0.4 to 0.7) 0.01 −0.02 NS −4.9 (−17.0 to 7.2);
p = 0.0618; 8 h
NE
4 ◦C 0.8 (0.6 to 0.9) 0.01 −0.02 NS 2.3 (−4.2 to 8.7);
p = 0.1814; 8 h
NE
BC-6800
RT 0.4 (0.3 to 0.5) 0.01 −0.01 NS 5.5 (−0.6 to 11.7);
p = 0.7159; 8 h
NE
4 ◦C 0.6 (0.5 to 0.7) 0.02 −0.13 NS 3.0 (−0.2 to 6.2);
p = 0.0279; 4 h
25.1  (7.9 to 42.3);
p < 0.0001; 8 ha
EO
(109/L)
XN-9000
RT  0.1 (0.0 to 0.4) 0.01 0.01 NS 43.4 (−16.0 to 102.7);
p = 0.2463; 8 h
NE
4 ◦C 0.1 (0.1 to 0.1) 0.01 0.02 NS 8.9 (1.7 to 16.0);
p = 0.7689; 4 h
31.5  (16.2 to 46.7);
p < 0.0001; 8 ha
BC-6800
RT  0.1 (0.0 to 0.4) 0.01 0.01 NS 29.0 (−6.0 to 65.2);
p = 0.0716; 4 h
29.6  (−6.2 to
65.3);
p < 0.05; 8 ha
4 ◦C 0.1 (0.1 to 0.2) 0.01 0.00 NS 7.3 (−19.7 to 34.4);
p = 0.8439; 8 h
NE
BA
(109/L)
XN-9000
RT  0.0 (0.0 to 0.0) 0.00 0.01 NS 32.7 (−8.2 to 73.6);
p = 0.2113; 8 h
NE
4 ◦C 0.0 (0.0 to 0.0) 0.00 0.01 NS 15.5 (−2.0 to 33.0);
p = 0.3737; 4 h
30.3  (17.8 to 42.8);
p < 0.0001; 8 ha
BC-6800
RT  0.0 (0.0 to 0.0) 0.00 0.00 NS 0.7 (−15.9 to 17.3);
p = 0.3829; 8 h
NE
4 ◦C 0.0 (0.0 to 0.0) 0.00 0.00 NS 7.1 (−16.1 to 30.4);
p = 0.9604; 8 h
NE
HFC
(109/L)
XN-9000
RT  0.0 (0.0 to 0.0) 0.00 0.00 NS −40.0 (−125.8 to 45.8)
CD% data not
available
4 ◦C 0.0 (0.0 to 0.0) 0.00 0.00 NS −21.3 (−54.8 to 12.3)
BC-6800
RT 0.0 (0.0 to 0.0) 0.00 0.00 NS 33.3 (−26.1 to 92.8)
4 ◦C 0.0 (0.0 to 0.0) 0.00 0.00 NS 4.3 (−59.0 to 67.5)
PLT
(109/L)
XN-9000
RT  264 (211 to 309) 0.8 16.4 NS 4.0 (−7.6 to 15.5);
p = 0.8577; 8 h
NE
4 ◦C 237 (188 to 270) 1.1 −1.7 NS −0.6 (−5.7 to 4.4);
p = 0.1548; 8 h
NE
BC-6800
RT 249 (209 to 286) 0.5 −8.0 NS −3.7 (−7.5 to 0.1);
p = 0.7113; 8 h
NE
4 ◦C 235 (178 to 276) −2.0 −9.0 NS −8.2 (−17.7 to 1.3);
p = 0.2672; 8 h
NE
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Table 5 – (Continued)
Temp T0 median value
(95% CI)
X (TX − T0)
Hodges–Lehmann
location shift
X  with
p-value < 0.0001
at the time [h]
B% (95% CI) a
time of stability;
p-value
B% vs. OP-Bias%;
Stable until [h]
B%  (95% CI);
p-value
B% vs. CD%;
Stable until [h]
4 h 8 h
MPV
(fL)
XN-9000
RT  10.7 (10.2 to 11.3) 0.10 0.05 NS 0.3 (−4.0 to 4.6);
p = 0.6606; 8 h
NE
4 ◦C 11.2 (10.6 to 12.0) 0.11 0.30 NS 1.0 (0.3 to 1.6);
p = 0.4789; 4 h
2.6% (1.4 to 3.8);
p < 0.0001; 8 ha
BC-6800
RT  9.7 (8.7 to 10.2) 0.30 0.40 NS 2.6 (1.5 to 3.7);
p < 0.0001b
3.7% (2.7 to 4.7);
p < 0.0001; 8 ha
4 ◦C 9.9 (9.4 to 10.5) 0.20 0.50 NS 2.7 (2.1 to 3.3);
p < 0.0001b
4.7% (3.7 to 5.9);
p < 0.0001; 8 ha
PDW
(fL)
XN-9000
RT  13.0 (11.3 to 15.1) 0.29 0.10 NS 0.3 (−7.4 to 8.1)
CD% data not
available
4 ◦C 13.2 (12.2 to 15.1) 0.20 0.60 NS 4.6 (2.1 to 7.2)
BC-6800
RT 15.9 (15.4 to 16.1) −0.05 0.00 NS 0.0 (−0.6 to 0.5)
4 ◦C 15.8 (15.7 to 16.1) 0.00 0.00 NS 0.1 (−0.5 to 0.7)
PCT
(%)
XN-9000
RT 0.3 (0.3 to 0.3) 0.00 0.01 NS 4.4 (−6.1 to 14.9)
4 ◦C 0.3 (0.2 to 0.3) 0.00 0.01 NS 2.1 (−3.4 to 7.5)
BC-6800
RT 0.2 (0.2 to 0.2) 0.00 0.00 NS −0.1 (−4.0 to 3.8)
4 ◦C 0.2 (0.2 to 0.3) 0.00 0.00 NS −4.2 (−13.8 to 5.4)
P-LCR
(%)
XN-9000
RT 31.3 (25.9 to 36.5) 1.36 0.72 NS 1.7 (−9.7 to 13.1)
4 ◦C 34.3 (29.4 to 40.3) 0.74 2.24 NS 6.5 (3.7 to 9.4)
BC-6800
RT 23.8 (15.5 to 29.7) −0.20 −0.30 NS 9.2 (6.7 to 11.7)
4 ◦C 24.5 (21.0 to 29.4) 1.40 3.95 NS 12.8 (8.8 to 16.7)
NE: neutrophil; RT: Room temperature; LY: lymphocyte; MO: monocyte; EO: eosinophil; BA: basophil; HFC: high ﬂuorescence cells; PLT: platelet;
MPV: mean volume platelet; PDW: PLT distribution width; PCT: plateletcrit; P-LCR: PLT larger cell ratio; NS: X not signiﬁcant throughout the
study period; NE: not evaluated; Temp: Temperature.
a Bias% (between baseline T0 and the time point X) is lower than CD%.
b
 thanBias% (between baseline T0 and the time point X) is always higher
collection in samples stored at RT (but not in those stored at
4 ◦C) when measured with both analyzers. The comparison
of the Bias% at different time points (TX) with the OP-Bias%
showed that HT is stable at room temperature for up to 8 h
using both the XN-9000 (Bias%: 0.9) and BC-6800 (Bias%: 1.9),
whereas the Bias% for HT in samples stored at RT remained
lower than the CD% for up to 24 h. The same analysis in
samples stored at 4 ◦C showed good stability for up to 24 h
after collection when compared with the OP-Bias%, whereas
the Bias% always remained lower than the CD% throughout
the study period (i.e., up to 48 h) using both analyzers.
The values of MCV  and RDW-SD displayed signiﬁcant differ-
ences after 24 h of storage at RT, whereas the results remained
substantially unchanged for up to 48 h after collection in sam-
ples stored a 4 ◦C. Interestingly, the Bias% of MCV exceeded
the OP-Bias% after 2 h of storage at RT with the XN-9000 and
after 8 h of storage at RT with the BC-6800, respectively. The
Bias% of MCV  was lower than the relative CD% for up to 8 h
of storage using both analyzers at RT. At variance, the Bias%
always remained lower than CD% throughout the study period
in samples stored at 4 ◦C. The RDW-CV exhibited signiﬁcant
variations after 24 h from collection using both analyzers at
RT, whereas signiﬁcant differences were observed after 24 h
of storage in samples stored at 4 ◦C using the XN-9000 but
not with the BC-6800 (Table 2). When compared with the OP-
Bias%, RDW-CV values were found to be stable for up to 8 h
at both RT and 4 ◦C using the XN-9000, and for up to 2 h at OP-Bias%.
RT with the BC-6800. The Bias% of RDW-CV was always lower
than the OP-Bias% for up to 48 h of storage using the BC-
6800.
At variance with previous parameters, the values of MCHC
displayed a speciﬁc and instrument-dependent variation.
More speciﬁcally, signiﬁcant differences were observed after
4 h of storage at RT and 2 h of storage at 4 ◦C with the XN-9000.
Accordingly, the Bias% exceeded the OP-Bias% at 2 h of storage
at both temperatures, whereas the Bias% did not exceed the
CD% for up to 8 h of storage at RT and for up to 48 h of storage
at 4 ◦C. As regards MCHC values obtained with the BC-6800,
signiﬁcant differences were found after 24 h of storage at RT
and at the 48 h time point after storage at 4 ◦C. The OP-Bias%
was exceeded after 8 h of storage at RT and 24 h of storage
at 4 ◦C, whereas the Bias% remained lower than the CD% for
up to 8 h of storage at RT and for up to 48 h of storage at 4 ◦C
(Table 2).
All these parameters appeared to be substantially stable for
up to 8 h at both RT and 4 ◦C in the abnormal samples group
using both analyzers. The most relevant exceptions are sum-
marized in Table 3. Speciﬁcally, the NRBC measured with the
XN-9000 showed signiﬁcant variations 8 h after collection in
samples stored at RT and 4 h after collection in those stored
at 4 ◦C, whereas signiﬁcant variations of NRBC measured with
the BC-6800 could only be observed after 8 h of storage at 4 ◦C.
The comparison between the Bias% and OP-Bias% for the MCH
and RDW-CV measured with the BC-6800 showed a signiﬁcant
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ariation after 4 h of storage at 4 ◦C. As regards the XN-9000,
nly the Bias% for MCHC increased over the OP-Bias% after 4 h
f storage at RT. Interestingly, the Bias% was found to be always
ower than the CD% for all parameters with both analyzers for
p to 8 h of storage at both temperatures.
eticulocytes
he baseline values of the different RET parameters were
ound to be always different on comparing the measurements
f the two hematological analyzers (Table 2). In the group of
ormal blood samples, RET and percentage of HFR were found
o be stable for up to 48 h using both analyzers and at both tem-
eratures. The Bias% of RET was found to be higher than the
P-Bias% after 36 h of storage at both temperatures. The per-
entages of IRF, LFR and MFR  were found to be higher than the
0 values after 24 h of storage at RT with the XN-9000 and after
6 h of storage at RT with the BC-6800 (Table 4). In the group of
bnormal blood samples all the RET parameters were found
o be stable for up to 8 h using both analyzers and at both
emperatures (Table 3).
eukocyte  count  and  differential
he baseline values of Leukocytes and DIFF counts did
ot exhibit statistically signiﬁcant variations throughout the
tudy period in the subgroup of normal samples, using both
nalyzers and at both temperatures, with the only exception
f the MO  measured with the BC-6800 at the 48-h time point
Table 4). Accordingly, the Bias% of MO  increased over the OP-
ias% after 36–48 h of storage at RT and after 24 h of storage at
◦C. Importantly, the Bias% was found to be always lower than
he CD% throughout the study period, using both analyzers
nd at both temperatures.
In the abnormal samples group the various parameters
ere also found to be stable up to 8 h of storage using both ana-
yzers and at both temperatures (Table 5). The OP-Bias% was
xceeded after 4 h for NE, LY and MO at 4 ◦C, and EO at RT using
he BC-6800. The Bias% of EO also exceeded the OP-Bias% after
 h of storage at 4 ◦C using the XN-9000 (Table 5).
latelets
ith the exception of PLT and PCT, the baseline values of
ll the PLT parameters were found to be signiﬁcantly differ-
nt between the two analyzers in the group of normal blood
amples (Table 4). In this group of specimens, PLT and PCT
arameters were found to be stable for up to 48 h at both
T and 4 ◦C using both analyzers (Table 4). The remaining
arameters (MPV, PDW, PCT and P-LCR) showed instrument-
ependent variations.
The Bias% of the PLT count measured with the XN-9000 was
ound to be higher than the OP-Bias% after 2 h of storage at
◦C, but remained always lower than the CD% for up to 48 h of
torage at this temperature. The values of MPV measured with
he XN-9000 signiﬁcantly increased after 24 h of storage at RT
nd at 48 h of storage at 4 ◦C. However, the variation of the MPV
as found to be higher than the OP-Bias% starting from 2 h of
torage at RT and 8 h of storage at 4 ◦C (Table 4). Importantly,
he Bias% of the MPV  never exceeded the CD% throughout the 1 6;3  8(3):225–239 237
48 h of storage. As regards the BC-6800, the MPV values were
signiﬁcantly increased after 4 h of storage at RT and 24 h of
storage at 4 ◦C. A Bias% larger than the OP-Bias% was observed
after 2 h of storage at RT, although it remained lower than the
CD% throughout the 24 h of storage at RT (Table 4). The values
of the PDW measured with both analyzers were found to be
signiﬁcantly different after 24 h of storage at RT, whereas sig-
niﬁcant differences in samples stored at 4 ◦C were observed
after 24 h of storage with the BC-6800 and after 48 h of storage
with the XN-9000 (Table 4).
In the group of abnormal samples, the PLT parameters were
found to be stable for up to 8 h using both analyzers at both
temperatures (Table 5). Nevertheless, the Bias% of the MPV
measured with the BC-6800 was found to be higher than the
OP-Bias% after 2 h of storage at both temperatures, whereas
the Bias% of the MPV  measured with the XN-9000 exceeded
the OP-Bias% after 4 h of storage at 4 ◦C. In no case, however,
the Bias% was found to be higher than the CD% in up to 8 h of
storage at both temperatures (Table 5).
Discussion
The ongoing reorganization of laboratory services around the
globe frequently entails the consolidation of small labs into
larger facilities.20 This process poses serious challenges to
sample quality, as sometimes blood specimens need to be
transported over long distances and for long periods of time.21
Therefore, the aim of our study was to obtain information
about sample stability for many  hematological parameters
measured with both the XN-9000 and BC-6800 analyzers. It
is hence not surprising that the stability data obtained in this
study were quite similar. Analyzer-speciﬁc trends were only
observed for a few parameters such as MCHC, MPV and MO.
More speciﬁcally, MCHC was found to be stable for longer at
both RT and 4 ◦C using the BC-6800, whereas the MPV  was
found to be stable for longer at 4 ◦C with the XN-9000. As the
analyzers use rather similar analytical techniques, the dif-
ferences seem to be attributable to a different technological
approach used to assess MCHC and MPV.
Overall, the stability appeared greater for normal samples
when they were stored at 4 ◦C compared to RT. A similar trend
was observed for abnormal samples, except for the NRBC
count as this parameter measured with the XN-9000 showed
a signiﬁcant variation after 4 h of storage at 4 ◦C and after 8 h
of storage at RT. When measured with the BC-6800, the NRBC
count was found to be stable throughout the study period at
RT, whereas a signiﬁcant change was found after 8 h of storage
at 4 ◦C (Table 3).
For the Sysmex XN-series, in accord with previous data
published by Briggs et al.,7 the values of WBC, NRBC and leuko-
cyte DIFF were found to be stable up to 48 h when normal
samples were stored at 4 ◦C. Tanaka et al. published data on
the stability of the PLT count,22 which are overall similar to
the results observed in this study (PLT seem to be stable for
up to 48 h in blood samples stored at both RT and at 4 ◦C). Dis-
crepant data were instead found comparing our results with
those obtained by Daves et al.23 and by Imeri et al.2 using the
Sysmex XN-series. Speciﬁcally, larger differences were found
for some RBC parameters in normal blood samples (i.e., MCH,
oter.
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MCV,  RDW-SD, PLT count and MPV). In these published inves-
tigations, the stability was found to be less than in the current
study in blood samples stored at both RT and 4 ◦C.
Conversely, the stability of MCHC values was found to be
less in our investigation than in the study published by Daves
et al.23 The differences are probably attributable to the use of
different pre-analytical procedures between studies. In fact,
our investigation was designed using strict criteria for the pre-
analytical phase (especially for collection and transportation
of normal samples), according to which the collection and
transportation of healthy samples was directly handled by
laboratory personnel. Similar evidence is unavailable in the
studies of Daves et al.23 and Imeri et al.,2 who preferred to
follow a different approach (i.e., blood collection and handling
by nurses), which is probably closer to the reality of routine
healthcare practices. Notably, no previous information is avail-
able for blood sample stability assessed with the BC-6800, so
that a direct comparison is unfeasible.
Interesting results emerge from the comparison between
the Bias% of the different analytes at different times and tem-
perature conditions, which may be useful for deﬁning the best
practice for the pre-analytical phase of routine hematological
testing. In the analysis of normal samples, the MCV  exhib-
ited a Bias% of −1.5% with the XN-9000 and a Bias% of −0.15%
with the BC-6800 in a sample stored for 8 h at RT. However,
the Bias% of MCHC and RDW-CV measured with the BC-6800
were −0.7% and 2.7% after 8 h of storage at RT and the Bias%
of MCHC measured with the XN-9000 was −2.4% after 8 h of
storage at RT. The HT exhibited a Bias% of 4.9% with both the
analyzers after 24 h at RT. After these periods of storage, the
variation of the parameters was found to be higher than the
CD%.
The major limitation of this study was the absence of stabil-
ity evaluation of pathological samples up to 72 h (i.e., 12 h, 24 h,
36 h and 72 h) as suggested in the ICSH guidelines.3,4 This was
not possible because the amount of each pathological sam-
ple included in this study was limited (only one tube for each
sample compared to three tubes for normal samples).
The results of this study show that the time and tem-
perature of storage can have an impact on the quality of
hematological testing, with results that may signiﬁcantly devi-
ate from the clinically allowable bias. Overall, we can hence
suggest that the blood samples should always be analyzed
within 2 h from collection regardless of storage temperature.
When the Bias% is compared to the CD%, the maximum time
for sample analysis can however be extended to up to 8 h.
Over 8 h it is not advisable to report the time or temperature-
sensitive parameters.
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